Search

Author/Creator Tebbutt, Niall C.

1. A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction. (8th July 2016)

Authors:
Shah, Manish A.; Cho, Jae-Yong; Tan, Iain B.; Tebbutt, Niall C.; Yen, Chia-Jui; Kang, Alice; Shames, David S.; Bu, Lilian; Kang, Yoon-Koo
Journal:
Oncologist
Issue:
Volume 21:Number 9(2016)
Page Start:
1085
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction. (8th July 2016)

Authors:
Shah, Manish A.; Cho, Jae‐Yong; Tan, Iain B.; Tebbutt, Niall C.; Yen, Chia‐Jui; Kang, Alice; Shames, David S.; Bu, Lilian; Kang, Yoon‐Koo
Journal:
Oncologist
Issue:
Volume 21:Number 9(2016)
Page Start:
1085
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. (November 2018)

Authors:
Salem, Mohamed E.; Yin, Jun; Weinberg, Benjamin A.; Renfro, Lindsay A.; Pederson, Levi D.; Maughan, Timothy S.; Adams, Richard A.; Van Cutsem, Eric; Falcone, Alfredo; Tebbutt, Niall C.; Seymour, Matthew T.; Díaz-Rubio, Eduardo; Aranda, Enrique; Bokemeyer, Carsten; Heinemann, Volker; Wasan, Harpre...
Journal:
European journal of cancer
Issue:
Volume 103(2018)
Page Start:
205
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3, 369 patients in the ARCAD database. (January 2023)

Authors:
Margalit, Ofer; Harmsen, William S.; Shacham-Shmueli, Einat; Voss, Molly M.; Boursi, Ben; Wagner, Anna D.; Cohen, Romain; Olswold, Curtis L.; Saltz, Leonard B.; Goldstein, Daniel A.; Hurwitz, Herbert; Tebbutt, Niall C.; Kabbinavar, Fairooz F.; Adams, Richard A.; Chibaudel, Benoist; Grothey, Axel;...
Journal:
European journal of cancer
Issue:
Volume 178(2023)
Page Start:
162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Is there a role for combined anti–PD‐1/CTLA‐4 checkpoint blockade in the management of advanced biliary tract cancers?. Issue 7 (24th January 2023)

Authors:
Klein, Oliver; Kee, Damien; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Behren, Andreas; Palmer, Jodie; Tebbutt, Niall C.; Carlino, Matteo S.; Cebon, Jonathan
Journal:
Cancer
Issue:
Volume 129:Issue 7(2023)
Page Start:
1129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. Issue 9 (14th June 2017)

Authors:
Yeung, Yvonne; Lau, David K.; Chionh, Fiona; Tran, Hoanh; Tse, Janson W. T.; Weickhardt, Andrew J.; Nikfarjam, Mehrdad; Scott, Andrew M.; Tebbutt, Niall C.; Mariadason, John M.
Journal:
Molecular oncology
Issue:
Volume 11:Issue 9(2017)
Page Start:
1130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Predictive value of chromosome 18q11.2‐q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III‐trial AGITG‐MAX. Issue 7 (23rd May 2022)

Authors:
van Dijk, Erik; van Werkhoven, Erik; Asher, Rebecca; Mooi, Jennifer K.; Espinoza, David; van Essen, Hendrik F.; van Tinteren, Harm; van Grieken, Nicole C. T.; Punt, Cornelis J. A.; Tebbutt, Niall C.; Ylstra, Bauke
Journal:
International journal of cancer
Issue:
Volume 151:Issue 7(2022)
Page Start:
1166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer. Issue 3 (24th January 2014)

Authors:
Bruhn, Maressa A.; Townsend, Amanda R.; Khoon Lee, Chee; Shivasami, Aravind; Price, Timothy J.; Wrin, Joe; Arentz, Georgia; Tebbutt, Niall C.; Hocking, Christopher; Cunningham, David; Hardingham, Jennifer E.; on behalf of the BHI in collaboration with AGITG
Journal:
International journal of cancer
Issue:
Volume 135:Issue 3(2014:Aug. 01)
Page Start:
731
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab1. (25th March 2013)

Authors:
Price, Timothy J.; Hardingham, Jennifer E.; Lee, Chee K.; Townsend, Amanda R.; Wrin, Joseph W.; Wilson, Kate; Weickhardt, Andrew; Simes, Robert J.; Murone, Carmel; Tebbutt, Niall C.
Journal:
Cancer medicine
Issue:
Volume 2:Number 3(2013:Jun.)
Page Start:
277
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗